Related Experiment Video
Updated: Apr 20, 2026
07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
18.9K
Biomarkers for personalized oncology: recent advances and future challenges
1Thomas Jefferson University, Philadelphia PA 19107.
Metabolism: Clinical and Experimental
|December 4, 2014
Summary
Oncology biomarkers are revolutionizing cancer care, enabling personalized treatments. Advances in genomic profiling allow precise matching of targeted therapies to individual tumors, improving outcomes for lung, breast, and other cancers.
Area of Science:
- Oncology and Cancer Research
- Molecular Diagnostics
- Genomics
Background:
- Cancer is characterized by uncontrolled cell growth; oncology studies tumors.
- Biomarker development in oncology has significantly advanced over the last decade.
- Understanding tumor molecular mechanisms drives new drug targets and treatments.
Purpose of the Study:
- To review the current state of knowledge regarding biomarkers in five selected cancers.
- To highlight the role of biomarkers in personalized oncotherapy.
- To discuss advances in molecular diagnostics and their impact on cancer treatment.
Main Methods:
- Review of recent advances in multiplex genotyping and next-generation sequencing.
- Analysis of biomarker-driven treatment algorithms in advanced-stage cancers.
- Examination of predictive and prognostic biomarkers in clinical practice.
Main Results:
- Biomarkers are shifting cancer care from empirical to molecularly-driven strategies.
- Next-generation sequencing enables comprehensive cancer genome analysis from small biopsies.
- Predictive biomarkers successfully match targeted therapies, reducing toxicity.
Conclusions:
- Biomarker-driven personalized oncotherapy is the current standard for advanced cancers.
- Targeted therapies like tyrosine kinase inhibitors and ALK inhibitors show efficacy.
- Biomarkers are crucial for evaluating targeted therapy benefits in chronic myeloid leukemia, colorectal, breast, lung cancer, and melanoma.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:50Combination Therapies and Personalized Medicine
1.9K
1.9K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:18Cancer
56.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.4K
02:49Cancer Therapies
3.0K
3.0K